Tactic Pharma Llc Monopar Therapeutics (MNPR) insider trading activity

MNPR Quotes by TradingView

Tactic Pharma LLC is > 10% Shareholder of Monopar Therapeutics. Currently has a direct ownership of 272,026 shares of MNPR, which is worth approximately $21.8 Million. The most recent transaction as insider was on Sep 24, 2025, when has been sold 550,229 shares (Common Stock) at a price of $63.61 per share, resulting in proceeds of $35,000,066. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 272K
66.92% 3M change
63.22% 12M change
Total Value Held $21.8 Million

Tactic Pharma LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 24 2025
SELL
Open market or private sale
$35,000,066 $63.61 p/Share
550,229 Reduced 66.92%
272,026 Common Stock
Apr 02 2025
SELL
Open market or private sale
$1,166,690 $35.0 p/Share
33,334 Reduced 3.9%
822,255 Common Stock
Feb 11 2021
SELL
Open market or private sale
$1,896,250 $15.17 p/Share
125,000 Reduced 42.86%
166,667 Common Stock
TPL

Tactic Pharma LLC

> 10% Shareholder
Wilmette, IL

Track Institutional and Insider Activities on MNPR

Follow Monopar Therapeutics and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MNPR shares.

Notify only if

Insider Trading

Get notified when an Monopar Therapeutics insider buys or sells MNPR shares.

Notify only if

News

Receive news related to Monopar Therapeutics

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MNPR